WASHINGTON - Members of Congress attacked new FDA user fees contained in the Clinton administration's fiscal 1998 budget proposal at a hearing of the House Appropriations Committee's agriculture subcommittee. The subcommittee chairman, Rep. Joe Skeen (R-N.M.) said it is unlikely that the new fees, which are being resisted by medical device manufacturers, will be enacted

Failure to approve the $132 million in new user fees would leave a hole in the FDA budget that could threaten the viability of the